(BLMN) Bloomin Brands - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0942351083
Stock: Casual Steakhouse, Italian Grill, Seafood, Fine Steakhouse
Total Rating 29
Risk 67
Buy Signal -0.22
| Risk 5d forecast | |
|---|---|
| Volatility | 78.0% |
| Relative Tail Risk | -8.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.04 |
| Alpha | -43.33 |
| Character TTM | |
|---|---|
| Beta | 0.917 |
| Beta Downside | 1.519 |
| Drawdowns 3y | |
|---|---|
| Max DD | 78.83% |
| CAGR/Max DD | -0.44 |
EPS (Earnings per Share)
Revenue
Description: BLMN Bloomin Brands February 26, 2026
Bloomin Brands, Inc. (NASDAQ: BLMN) operates a portfolio of four restaurant concepts-Outback Steakhouse, Carrabba’s Italian Grill, Bonefish Grill, and Fleming’s Prime Steakhouse & Wine Bar-through both company-owned and franchised locations across the United States and internationally. Founded in 1988 and headquartered in Tampa, Florida, the firm is classified under the GICS Restaurants sub-industry.
In its most recent quarter (Q4 2025), Bloomin Brands reported revenue of $1.02 billion, a 5.2% year-over-year increase, driven by a 4.5% rise in comparable restaurant sales and a 6% boost in franchise royalties. Net income climbed to $78 million, reflecting improved cost controls amid a modest easing of inflationary pressure on food and labor inputs. The broader restaurant sector continues to benefit from a 3% annual growth in consumer discretionary spending and a gradual stabilization of commodity prices, which together support demand for both casual and fine-dining experiences.
For a deeper dive into Bloomin Brands’ valuation metrics and how they compare within the restaurant sector, you might explore the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 8.24m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 1.92 > 1.0 |
| NWC/Revenue: -15.83% < 20% (prev -16.52%; Δ 0.69% < -1%) |
| CFO/TA 0.09 > 3% & CFO 276.7m > Net Income 8.24m |
| Net Debt (3.01b) to EBITDA (219.7m): 13.70 < 3 |
| Current Ratio: 0.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (85.2m) vs 12m ago 0.43% < -2% |
| Gross Margin: 55.75% > 18% (prev 0.14%; Δ 5561 % > 0.5%) |
| Asset Turnover: 120.7% > 50% (prev 113.0%; Δ 7.69% > 0%) |
| Interest Coverage Ratio: 0.93 > 6 (EBITDA TTM 219.7m / Interest Expense TTM 45.4m) |
Altman Z'' -2.49
| A: -0.20 (Total Current Assets 252.5m - Total Current Liabilities 878.6m) / Total Assets 3.17b |
| B: -0.29 (Retained Earnings -917.6m / Total Assets 3.17b) |
| C: 0.01 (EBIT TTM 42.0m / Avg Total Assets 3.28b) |
| D: -0.32 (Book Value of Equity -907.6m / Total Liabilities 2.83b) |
| Altman-Z'' Score: -2.49 = D |
Beneish M
| DSRI: 0.86 (Receivables 102.2m/114.6m, Revenue 3.96b/3.82b) |
| GMI: 0.25 (GM 55.75% / 13.85%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.03 (Revenue 3.96b / 3.82b) |
| TATA: -0.08 (NI 8.24m - CFO 276.7m) / TA 3.17b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of BLMN shares?
As of March 04, 2026, the stock is trading at USD 6.35 with a total of 3,079,779 shares traded.
Over the past week, the price has changed by +8.18%, over one month by +2.58%, over three months by -7.70% and over the past year by -20.44%.
Over the past week, the price has changed by +8.18%, over one month by +2.58%, over three months by -7.70% and over the past year by -20.44%.
Is BLMN a buy, sell or hold?
Bloomin Brands has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold BLMN.
- StrongBuy: 1
- Buy: 0
- Hold: 10
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the BLMN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 7.4 | 15.7% |
| Analysts Target Price | 7.4 | 15.7% |
BLMN Fundamental Data Overview March 04, 2026
P/E Trailing = 17.0811
P/E Forward = 6.8166
P/S = 0.1361
P/B = 1.5157
P/EG = 1.07
Revenue TTM = 3.96b USD
EBIT TTM = 42.0m USD
EBITDA TTM = 219.7m USD
Long Term Debt = 962.2m USD (from longTermDebt, two quarters ago)
Short Term Debt = 179.7m USD (from shortTermDebt, last quarter)
Debt = 3.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.01b USD (from netDebt column, last quarter)
Enterprise Value = 3.55b USD (538.6m + Debt 3.07b - CCE 59.5m)
Interest Coverage Ratio = 0.93 (Ebit TTM 42.0m / Interest Expense TTM 45.4m)
EV/FCF = 36.65x (Enterprise Value 3.55b / FCF TTM 96.8m)
FCF Yield = 2.73% (FCF TTM 96.8m / Enterprise Value 3.55b)
FCF Margin = 2.45% (FCF TTM 96.8m / Revenue TTM 3.96b)
Net Margin = 0.21% (Net Income TTM 8.24m / Revenue TTM 3.96b)
Gross Margin = 55.75% ((Revenue TTM 3.96b - Cost of Revenue TTM 1.75b) / Revenue TTM)
Gross Margin QoQ = 70.20% (prev 70.38%)
Tobins Q-Ratio = 1.12 (Enterprise Value 3.55b / Total Assets 3.17b)
Interest Expense / Debt = 0.40% (Interest Expense 12.4m / Debt 3.07b)
Taxrate = 21.0% (US default 21%)
NOPAT = 33.2m (EBIT 42.0m * (1 - 21.00%))
Current Ratio = 0.29 (Total Current Assets 252.5m / Total Current Liabilities 878.6m)
Debt / Equity = 9.20 (Debt 3.07b / totalStockholderEquity, last quarter 333.6m)
Debt / EBITDA = 13.70 (Net Debt 3.01b / EBITDA 219.7m)
Debt / FCF = 31.09 (Net Debt 3.01b / FCF TTM 96.8m)
Total Stockholder Equity = 363.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.25% (Net Income 8.24m / Total Assets 3.17b)
RoE = 2.26% (Net Income TTM 8.24m / Total Stockholder Equity 363.9m)
RoCE = 3.16% (EBIT 42.0m / Capital Employed (Equity 363.9m + L.T.Debt 962.2m))
RoIC = 2.54% (NOPAT 33.2m / Invested Capital 1.31b)
WACC = 1.66% (E(538.6m)/V(3.61b) * Re(9.29%) + D(3.07b)/V(3.61b) * Rd(0.40%) * (1-Tc(0.21)))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -5.90%
[DCF] Terminal Value 83.41% ; FCFF base≈73.4m ; Y1≈57.1m ; Y5≈36.7m
[DCF] Fair Price = N/A (negative equity: EV 1.13b - Net Debt 3.01b = -1.88b; debt exceeds intrinsic value)
EPS Correlation: -68.63 | EPS CAGR: -25.90% | SUE: 0.24 | # QB: 0
Revenue Correlation: -47.55 | Revenue CAGR: -4.09% | SUE: -0.00 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.23 | Chg7d=+0.000 | Chg30d=-0.001 | Revisions Net=-1 | Analysts=13
EPS current Year (2026-12-31): EPS=0.86 | Chg7d=-0.001 | Chg30d=-0.006 | Revisions Net=-4 | Growth EPS=-24.5% | Growth Revenue=+0.1%
EPS next Year (2027-12-31): EPS=0.98 | Chg7d=-0.083 | Chg30d=-0.090 | Revisions Net=-6 | Growth EPS=+13.4% | Growth Revenue=+1.8%
[Analyst] Revisions Ratio: -0.09 (5 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.4% (Discount Rate 9.3% - Earnings Yield 5.9%)
[Growth] Growth Spread = -3.5% (Analyst -0.1% - Implied 3.4%)
P/E Forward = 6.8166
P/S = 0.1361
P/B = 1.5157
P/EG = 1.07
Revenue TTM = 3.96b USD
EBIT TTM = 42.0m USD
EBITDA TTM = 219.7m USD
Long Term Debt = 962.2m USD (from longTermDebt, two quarters ago)
Short Term Debt = 179.7m USD (from shortTermDebt, last quarter)
Debt = 3.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.01b USD (from netDebt column, last quarter)
Enterprise Value = 3.55b USD (538.6m + Debt 3.07b - CCE 59.5m)
Interest Coverage Ratio = 0.93 (Ebit TTM 42.0m / Interest Expense TTM 45.4m)
EV/FCF = 36.65x (Enterprise Value 3.55b / FCF TTM 96.8m)
FCF Yield = 2.73% (FCF TTM 96.8m / Enterprise Value 3.55b)
FCF Margin = 2.45% (FCF TTM 96.8m / Revenue TTM 3.96b)
Net Margin = 0.21% (Net Income TTM 8.24m / Revenue TTM 3.96b)
Gross Margin = 55.75% ((Revenue TTM 3.96b - Cost of Revenue TTM 1.75b) / Revenue TTM)
Gross Margin QoQ = 70.20% (prev 70.38%)
Tobins Q-Ratio = 1.12 (Enterprise Value 3.55b / Total Assets 3.17b)
Interest Expense / Debt = 0.40% (Interest Expense 12.4m / Debt 3.07b)
Taxrate = 21.0% (US default 21%)
NOPAT = 33.2m (EBIT 42.0m * (1 - 21.00%))
Current Ratio = 0.29 (Total Current Assets 252.5m / Total Current Liabilities 878.6m)
Debt / Equity = 9.20 (Debt 3.07b / totalStockholderEquity, last quarter 333.6m)
Debt / EBITDA = 13.70 (Net Debt 3.01b / EBITDA 219.7m)
Debt / FCF = 31.09 (Net Debt 3.01b / FCF TTM 96.8m)
Total Stockholder Equity = 363.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.25% (Net Income 8.24m / Total Assets 3.17b)
RoE = 2.26% (Net Income TTM 8.24m / Total Stockholder Equity 363.9m)
RoCE = 3.16% (EBIT 42.0m / Capital Employed (Equity 363.9m + L.T.Debt 962.2m))
RoIC = 2.54% (NOPAT 33.2m / Invested Capital 1.31b)
WACC = 1.66% (E(538.6m)/V(3.61b) * Re(9.29%) + D(3.07b)/V(3.61b) * Rd(0.40%) * (1-Tc(0.21)))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -5.90%
[DCF] Terminal Value 83.41% ; FCFF base≈73.4m ; Y1≈57.1m ; Y5≈36.7m
[DCF] Fair Price = N/A (negative equity: EV 1.13b - Net Debt 3.01b = -1.88b; debt exceeds intrinsic value)
EPS Correlation: -68.63 | EPS CAGR: -25.90% | SUE: 0.24 | # QB: 0
Revenue Correlation: -47.55 | Revenue CAGR: -4.09% | SUE: -0.00 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.23 | Chg7d=+0.000 | Chg30d=-0.001 | Revisions Net=-1 | Analysts=13
EPS current Year (2026-12-31): EPS=0.86 | Chg7d=-0.001 | Chg30d=-0.006 | Revisions Net=-4 | Growth EPS=-24.5% | Growth Revenue=+0.1%
EPS next Year (2027-12-31): EPS=0.98 | Chg7d=-0.083 | Chg30d=-0.090 | Revisions Net=-6 | Growth EPS=+13.4% | Growth Revenue=+1.8%
[Analyst] Revisions Ratio: -0.09 (5 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.4% (Discount Rate 9.3% - Earnings Yield 5.9%)
[Growth] Growth Spread = -3.5% (Analyst -0.1% - Implied 3.4%)